Brief: Nexalin Technology Receives IRB Approval In Brazil And Begins Clinical Trial For Anxiety And Insomnia
24/04/2025 14:05
April 24 (Reuters) - Nexalin Technology Inc NXL.O: NEXALIN TECHNOLOGY RECEIVES IRB APPROVAL IN BRAZIL AND BEGINS CLINICAL TRIAL FOR ANXIETY AND INSOMNIA Source text: ID:nGNEh93 Further company coverage: NXL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nexalin Technology
See all newsBrief: Nexalin Technology Regains Compliance With Nasdaq Minimum Bid Price Requirement Nasdaq Hearings Panel Grants Request For Continued Listing
NASDAQ RESUMED AT 12:48 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:43 PM
NASDAQ RESUMED AT 10:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:24 AM